Akèy › Hidradénite suppurative › Alabama › Birmingham
Etid klinik pou Hidradénite suppurative nan Birmingham, AL
5 etid pou Hidradénite suppurative ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Ap rekriteFaz 2
- Oruka Therapeutics Investigative Site, Birmingham
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Ap rekriteEtid obsèvasyon
- Whitaker Clinic, Birmingham
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Ap rekriteFaz 3
- Investigative Site US106, Birmingham
- Investigative Site US086, Birmingham
Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Ap rekriteFaz 1 bonè
- University of Alabama at Birmingham, Birmingham
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Ap rekriteFaz 2
- University of Alabama At Birmingham, Birmingham
Etid Hidradénite suppurative nan lòt vil
- Boston, MA9 etid
- Tampa, FL7 etid
- Miami, FL6 etid
- New York City, NY5 etid
- Dallas, TX5 etid
- Phoenix, AZ5 etid
- New Orleans, LA4 etid
- Santa Clarita, CA4 etid
- Scottsdale, AZ4 etid
- Durham, NC4 etid
- Minneapolis, MN4 etid
- Philadelphia, PA4 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)31 etid
- Kansè nan tete24 etid
- Kansè ovè23 etid
- Obèsite23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Dyabèt Tip 216 etid
- Kansè Endomèt16 etid
- Sipwa16 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.